97 results on '"Grohé, Christian"'
Search Results
2. Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP).
3. Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
4. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?
5. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms.
6. Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial.
7. Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study.
8. Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study.
9. Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome.
10. Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry.
11. Arthritiden und Lungenkavernen.
12. Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.
13. Post-COVID und die Lunge.
14. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
15. Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.
16. Update 2021: Pulmonale Folgen nach COVID-19-Pneumonie.
17. Optimizing therapy sequence to prevent patient attrition in EGFR mutation-positive advanced or metastatic NSCLC.
18. Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.
19. COVID-19 aus Sicht der Pneumologie – Langzeitfolgen und Implikationen für die pneumologische Nachsorge.
20. Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort.
21. Begutachtung von Berufskrankheiten am Beispiel pneumologischer Erkrankungen.
22. Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.
23. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.
24. Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
25. Hyponatremia in Oncology Patients.
26. Neuroendokrine Neoplasien im deutschen NET-Register.
27. Kommentar.
28. Intersektorale Konzepte zur außerklinischen Beatmung.
29. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
30. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
31. SIADH: differential diagnosis and clinical management.
32. Aktuelle Therapieansätze der Sarkoidose.
33. ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.
34. Lingua Villosa Nigra Following Initiation of Antibiotic Treatment for Multidrug-Resistant Tuberculosis.
35. Die Zeitenwende der chronisch fibrosierenden Lungengerüsterkrankung.
36. Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
37. Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
38. Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib.
39. Sex and Gender Differences in Pulmonary Diseases.
40. Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany.
41. TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo.
42. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
43. A Novel Sarcoidosis Risk Locus for Europeans on Chromosome 11q13.1.
44. Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study.
45. VEGF Gene Haplotypes Are Associated With Sarcoidosis.
46. Lack of gelsolin promotes perpetuation of atrial fibrillation in the mouse heart.
47. Toll-Like Receptor 2 Gene Polymorphisms Arg677Trp and Arg753Gln in Chronic Obstructive Pulmonary Disease.
48. Polymorphisms of the ß2 adrenoreceptor gene in chronic obstructive pulmonary disease.
49. Differenzialdiagnose Lungenerkrankung – Wie sich das Häufige mit dem Seltenen erklären lässt!
50. Sex-specific pathways in early cardiac response to pressure overload in mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.